Validation of a French Version of the Confusion Assessment Method (CAM)
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Jan 23, 2013
Trial Information
Current as of June 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A family member of the patient, or his/her "trusted person" must have given his/her informed and signed consent
- • The patient must be insured or beneficiary of a health insurance plan
- • Hospitalization in geriatric short stay OR patient consulting at a geriatric assessment center / memory clinic OR geriatric day hospitalization
- * Patients for whom a state of confusion is suspected during the pre-inclusion visit run-in based on the following criteria:
- • Presence of a cognitive function disorder as defined by a score greater than or equal to 3 on the Short Portable Mental Status Questionnaire (SPMSQ) (Pfeiffer E, 1975) AND / OR
- • Presence of a mood disorder and / or behavior disorder (regardless of duration) according to the patient's family or caregivers
- • Presence of a caregiver who can answer questionnaires concerning activities of everyday life
- Exclusion Criteria:
- • The patient is participating in another study
- • The patient is in an exclusion period determined by a previous study
- • The patient's family or "trusted-person" refuses to sign the consent
- • The patient does not understand french
- • Severe aphasia
- • Stay is \< = 3 days
About Centre Hospitalier Universitaire De Nīmes
The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reims, , France
Alès, , France
Ivry Sur Seine Cedex, , France
Nîmes Cedex 09, , France
Bois Guillaume, , France
Marseille, , France
Montpellier Cedex 5, , France
Nice, , France
Patients applied
Trial Officials
Valéry Antoine, MD
Principal Investigator
Centre Hospitalier Universitaire de Nîmes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials